Buchumschlag

Radionuclides in drug development

Recently, molecular imaging has gained broad interest for the stratification procedures in personalized therapies. In this regard, the importance of radionuclides for the drug development process shall not be underestimated. The methods range from target identification, pharmacokinetics studies, Pha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Uhl, Philipp (VerfasserIn) , Fricker, Gert (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Mier, Walter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2015
In: Drug discovery today
Year: 2015, Jahrgang: 20, Heft: 2, Pages: 198-208
ISSN:1878-5832
DOI:10.1016/j.drudis.2014.09.027
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.drudis.2014.09.027
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1359644614003961
Volltext
Verfasserangaben:Philipp Uhl, Gert Fricker, Uwe Haberkorn and Walter Mier

MARC

LEADER 00000caa a2200000 c 4500
001 1560408375
003 DE-627
005 20230428071310.0
007 cr uuu---uuuuu
008 170703s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.drudis.2014.09.027  |2 doi 
035 |a (DE-627)1560408375 
035 |a (DE-576)490408370 
035 |a (DE-599)BSZ490408370 
035 |a (OCoLC)1340976522 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Uhl, Philipp  |e VerfasserIn  |0 (DE-588)1112349391  |0 (DE-627)866420797  |0 (DE-576)476575230  |4 aut 
245 1 0 |a Radionuclides in drug development  |c Philipp Uhl, Gert Fricker, Uwe Haberkorn and Walter Mier 
264 1 |c February 2015 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.07.2017 
520 |a Recently, molecular imaging has gained broad interest for the stratification procedures in personalized therapies. In this regard, the importance of radionuclides for the drug development process shall not be underestimated. The methods range from target identification, pharmacokinetics studies, Phase 0 microdosing studies, endoradiotherapy with low molecular weight drugs to radioimmunotherapeutics such as Zevalin®. This review provides a comprehensive overview of the use of radionuclides in medical sciences from autoradiography over radioimmunoassay, post-labeling and target identification to the determination of the pharmacokinetics and metabolization and molecular imaging techniques. We demonstrate the enormous potential of different radionuclides with respect to specific classes of drugs, the radiolabeling procedures and their limitations, the instrumentation technologies and their implementation in the drug development process. 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
773 0 8 |i Enthalten in  |t Drug discovery today  |d Amsterdam [u.a.] : Elsevier Science, 1996  |g 20(2015), 2, Seite 198-208  |h Online-Ressource  |w (DE-627)306658348  |w (DE-600)1500337-1  |w (DE-576)259270970  |x 1878-5832  |7 nnas  |a Radionuclides in drug development 
773 1 8 |g volume:20  |g year:2015  |g number:2  |g pages:198-208  |g extent:11  |a Radionuclides in drug development 
856 4 0 |u http://dx.doi.org/10.1016/j.drudis.2014.09.027  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1359644614003961  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170703 
993 |a Article 
994 |a 2015 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 4  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 2 
998 |g 1112349391  |a Uhl, Philipp  |m 1112349391:Uhl, Philipp  |d 910000  |d 911400  |e 910000PU1112349391  |e 911400PU1112349391  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1560408375  |e 297307309X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"name":{"displayForm":["Philipp Uhl, Gert Fricker, Uwe Haberkorn and Walter Mier"]},"note":["Gesehen am 03.07.2017"],"person":[{"role":"aut","family":"Uhl","given":"Philipp","display":"Uhl, Philipp"},{"given":"Gert","display":"Fricker, Gert","family":"Fricker","role":"aut"},{"given":"Uwe","display":"Haberkorn, Uwe","family":"Haberkorn","role":"aut"},{"given":"Walter","display":"Mier, Walter","role":"aut","family":"Mier"}],"recId":"1560408375","physDesc":[{"extent":"11 S."}],"id":{"eki":["1560408375"],"doi":["10.1016/j.drudis.2014.09.027"]},"title":[{"title_sort":"Radionuclides in drug development","title":"Radionuclides in drug development"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"February 2015"}],"relHost":[{"title":[{"title_sort":"Drug discovery today","title":"Drug discovery today"}],"id":{"issn":["1878-5832"],"eki":["306658348"],"zdb":["1500337-1"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1996","dateIssuedDisp":"1996-","publisher":"Elsevier Science"}],"recId":"306658348","disp":"Radionuclides in drug developmentDrug discovery today","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"pages":"198-208","extent":"11","issue":"2","text":"20(2015), 2, Seite 198-208","year":"2015","volume":"20"},"pubHistory":["1.1996 -"],"note":["Gesehen am 08.02.2021"]}]} 
SRT |a UHLPHILIPPRADIONUCLI2015 

Ähnliche Einträge